Company record
HTO Nevada, Inc. dba Kirkman
1 FDA warning letter since 2023 and 3 recalls in the last 12 months.
Get an email the day FDA posts anything new about HTO Nevada, Inc. dba Kirkman.
Warning letters
-
DrugsHTO Nevada, Inc. dba Kirkman
HTO Nevada dba Kirkman, an OTC drug contract manufacturer, was cited for CGMP violations including mislabeled reformulated drugs.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Mar 11 | Class II | HTO Nevada Inc. dba Kirkman Drug |
FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016. Stability Data Does Not Support Expiry Date. |
| Mar 11 | Class II | HTO Nevada Inc. dba Kirkman Drug |
MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015. Stability Data Does Not Support Expiry Date. |
| Mar 11 | Class II | HTO Nevada Inc. dba Kirkman Drug |
MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014. Stability Data Does Not Support Expiry Date. |